Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1440

TETRACYCLINE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12

Basic Information

ChEMBL ID CHEMBL1440
Name TETRACYCLINE
Phase Approved
Structure Type MOL
InChI Key OFVLGDICTFRJMM-WESIUVDSSA-N
Therapeutic ✓ Yes

Known Names

Achromycin v E701 Economycin NSC-108579 Panmycin Supramycin Sustamycin Tetrabid organon Tetraciclina Tetracycline Tetracycline component of pylera Vetquamycin
19
Targets
42
Activities
1
Assay Types
30
PK Parameters
20
Publications
12
Known Names
17
Indications
1
Mechanisms

Molecular Properties

444.4
MW (Da)
-0.21
ALogP
9
HBA
6
HBD
181.6
PSA (Ų)
0.34
QED
1
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1953
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral Parenteral Topical

Flags

Natural Product
USAN Stem -cycline

Extended Properties

Molecular Formula C22H24N2O8
MW 444.44
Aromatic Rings 1
Heavy Atoms 32
NP-Likeness 1.70

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Bacterial 70S ribosome inhibitor INHIBITOR Bacterial 70S ribosome

Indications

Bacterial Infections Eye Infections Infections Candidiasis, Vulvovaginal Conjunctivitis, Inclusion Helicobacter Infections Periodontitis Vaginosis, Bacterial Burns Lyme Disease Lymphoma, Non-Hodgkin Multiple Sclerosis Multiple Sclerosis, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Acne Vulgaris Chalazion Osteomyelitis

ATC Classification

A01AB13
tetracycline
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: STOMATOLOGICAL PREPARATIONS
D06AA04
tetracycline
Level 1: DERMATOLOGICALS
Level 2: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
J01AA07
tetracycline
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIBACTERIALS FOR SYSTEMIC USE
S01AA09
tetracycline
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
S02AA08
tetracycline
Level 1: SENSORY ORGANS
Level 2: OTOLOGICALS
S03AA02
tetracycline
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS

Activity Summary

IC50 42 meas. best 6.51

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Klebsiella pneumoniae
CHEMBL350
IC50 6.51 6.51 312.0 1
Plasmodium falciparum
CHEMBL364
IC50 6.49 6.23 323.9 5
Mycolicibacterium smegmatis
CHEMBL613088
IC50 6.48 6.435 330.0 2
Dermabacter hominis
CHEMBL1169592
IC50 5.92 5.92 1200.0 1
Bacillus subtilis
CHEMBL359
IC50 5.9 5.9 1250.0 1
Pseudomonas aeruginosa
CHEMBL348
IC50 5.9 5.9 1250.0 1
Escherichia coli
CHEMBL354
IC50 5.85 5.306 1400.0 5
Bacterial 70S ribosome
CHEMBL2363135
IC50 5.34 5.34 4580.0 1
Staphylococcus aureus
CHEMBL352
IC50 5.24 5.24 5700.0 1
Alpha-synuclein
CHEMBL6152
IC50 5.22 5.22 6060.0 1
HaCaT
CHEMBL614392
IC50 5.1 5.1 8000.0 1
Tyrosine-protein phosphatase non-receptor type 7
CHEMBL2219
IC50 5.08 5.08 8330.0 1
Staphylococcus auricularis
CHEMBL5291674
IC50 5.0 5.0 10000.0 1
Multidrug transporter MdfA
CHEMBL4785
IC50 4.88 4.88 13200.0 1
Brevibacterium epidermidis
CHEMBL1169591
IC50 4.86 4.86 13900.0 1
Heat shock protein HSP90
CHEMBL2095165
IC50 4.65 4.65 22447.4 1
ADMET
CHEMBL612558
IC50 4.38 4.38 41600.0 1
HeLa
CHEMBL399
IC50 4.29 4.29 51000.0 1
Unchecked
CHEMBL612545
IC50 4.22 4.22 60300.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC - - Mus musculus
AUC 802.0 ng.hr.mL-1 Rattus norvegicus
AUC 802.0 ng.hr.mL-1 Rattus norvegicus
AUC 3083.0 ng.hr.mL-1 Rattus norvegicus
AUC 4536.0 ng.hr.mL-1 Rattus norvegicus
CL 1.5 mL.min-1.kg-1 Homo sapiens
CL 1.5 mL.min-1.kg-1 Homo sapiens
CL 0.6 mL.min-1.kg-1 Homo sapiens
CL 1.5 mL.min-1.kg-1 Homo sapiens
CL 20.5 mL.min-1.kg-1 Rattus norvegicus
CL 20.5 mL.min-1.kg-1 Rattus norvegicus
CL 9.033 mL.min-1.kg-1 Rattus norvegicus
Cmax - - Mus musculus
Cmax 3825.04 nM Homo sapiens
Cmax 1311.76 nM Rattus norvegicus
F 77.0 % Homo sapiens
F 78.0 % Homo sapiens
F 12.1 % Rattus norvegicus
F 12.0 % Rattus norvegicus
F 14.9 % Rattus norvegicus
F 60.0 % Homo sapiens
F 50.0 % Homo sapiens
F 14.9 % Rattus norvegicus
F 6.3 % Mus musculus
Fu 0.78 - Homo sapiens
Fu 0.78 - Homo sapiens
MRT 12.0 hr Homo sapiens
T1/2 9.4 hr Homo sapiens
T1/2 4.5 hr Rattus norvegicus
T1/2 4.5 hr Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Klebsiella pneumoniae IC50 = 312.0 nM 6.51 Antibacterial activity against Klebsiella pneumoniae assessed as reduction in ba... 30119011
Plasmodium falciparum IC50 = 323.9 nM 6.49 Antimalarial activity after 96 hrs against azithromycin-resistant Plasmodium fal... 17110371
Mycolicibacterium smegmatis IC50 = 330.0 nM 6.48 Antimycobacterial activity against Mycobacterium smegmatis by GFP-based fluoresc... 19786608
Plasmodium falciparum IC50 = 364.7 nM 6.44 Antimalarial activity after 96 hrs against azithromycin-resistant Plasmodium fal... 17110371
Plasmodium falciparum IC50 = 397.1 nM 6.4 Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 by [3H]hypo... 17110371
Mycolicibacterium smegmatis IC50 = 410.0 nM 6.39 Antimycobacterial activity against Mycobacterium smegmatis assessed as growth in... 19786608
Plasmodium falciparum IC50 = 696.7 nM 6.16 Antimalarial activity after 96hrs against Plasmodium falciparum 7G8 by [3H]hypox... 17110371
Dermabacter hominis IC50 = 1200.0 nM 5.92 Antibacterial activity against Dermabacter hominis DSM 7083 after 48 hrs by micr... 20545334
Pseudomonas aeruginosa IC50 = 1250.0 nM 5.9 Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in b... 30119011
Bacillus subtilis IC50 = 1250.0 nM 5.9 Antibacterial activity against Bacillus subtilis assessed as reduction in bacter... 30119011
Escherichia coli IC50 = 1400.0 nM 5.85 Inhibition of transcription-translation process in Escherichia coli 26288696
Plasmodium falciparum IC50 = 2190.0 nM 5.66 Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after... 17060533
Escherichia coli IC50 = 2800.0 nM 5.55 Inhibition of protein synthesis in Escherichia coli S30 extracts by coupled tran... 16890435
Escherichia coli IC50 = 2800.0 nM 5.55 Inhibition of protein synthesis in Escherichia coli by coupled transcription-tra... 17188860
Bacterial 70S ribosome IC50 = 4580.0 nM 5.34 Inhibition of Escherichia coli ribosome-mediated translation after 60 mins by tr... 22148514
Staphylococcus aureus IC50 = 5700.0 nM 5.24 Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 16 hrs by ... 24856903
Alpha-synuclein IC50 = 6060.0 nM 5.22 Inhibition of alpha-synuclein fibril formation (unknown origin) incubated for 24... 30743095
HaCaT IC50 = 8000.0 nM 5.1 Cytotoxicity against human HaCaT cells after 24 hrs by MTT assay 34223166
Tyrosine-protein phosphatase non-receptor type 7 IC50 = 8330.0 nM 5.08 PUBCHEM_BIOASSAY: HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Targ... -
Escherichia coli IC50 = 10000.0 nM 5.0 Antibacterial activity against Escherichia coli assessed as reduction in bacteri... 30119011

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL3885861 Rattus norvegicus 1453
- 10.6019/CHEMBL3885881 Rattus norvegicus 270
19164140 10.1128/aac.00822-08 Klebsiella aerogenes 62
17620376 10.1128/aac.00625-07 Escherichia coli 48
17043131 10.1128/aac.00600-06 Salmonella typhimurium 44
18443112 10.1128/aac.00084-08 Salmonella typhimurium 41
20713660 10.1128/aac.00009-10 Pseudomonas aeruginosa 36
17387155 10.1128/aac.00062-07 Cutibacterium acnes 36
19164140 10.1128/aac.00822-08 Klebsiella pneumoniae 34
20145081 10.1128/aac.00737-08 Bacillus anthracis 29
19738019 10.1128/aac.00724-09 NON-PROTEIN TARGET 28
19273677 10.1128/aac.01464-08 Streptococcus pneumoniae 27
17325224 10.1128/aac.00187-07 Streptococcus pneumoniae 26
18378705 10.1128/aac.01420-07 Neisseria gonorrhoeae 24
17158933 10.1128/aac.01052-06 Staphylococcus lugdunensis 23
19596873 10.1128/aac.00546-09 Streptococcus intermedius 23
19651906 10.1128/aac.00624-09 Staphylococcus simulans 18
19651906 10.1128/aac.00624-09 Staphylococcus hominis 18
19651906 10.1128/aac.00624-09 Staphylococcus aureus 18
18070962 10.1128/aac.00375-07 Escherichia coli 18

Data from ChEMBL 36 via Core Engine